ALB and Miyoshi myopathy: Furthermore, the 5-year OS was shorter among those with sCD229 levels >5.0 ng/mL compared with those ≤5.0 ng/mL (39.1 vs. 61.0%; HR 2.3; p = 0.01) (Figure 8B) However, when variables related to a worse prognosis in patients with newly diagnosed MM were included in the multivariate Cox regression models for PFS and OS, it was observed that the levels of hemoglobin, albumin and sCD229 lost their prognostic impact, but not age and β2-microglobulin (Table S1).